Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-17-067368
Filing Date
2017-12-27
Accepted
2017-12-27 13:31:58
Documents
2
Period of Report
2017-12-18

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2171
2 POA DOCUMENT poa.txt EX-24.3_758628 3916
  Complete submission text file 0001209191-17-067368.txt   7562
Mailing Address 3600 GREEN COURT, SUITE 350 ANN ARBOR MI 48105
Business Address
DIGIANDOMENICO ANTHONY (Reporting) CIK: 0001083544 (see all company filings)

State of Incorp.: CA | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-38327 | Film No.: 171275810

Mailing Address 675 W. KENDALL STREET CAMBRIDGE MA 02142
Business Address 675 W. KENDALL STREET CAMBRIDGE MA 02142 617-949-2680
Cue Biopharma, Inc. (Issuer) CIK: 0001645460 (see all company filings)

EIN.: 473324577 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations